Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Samba-01: Inhaled insulin pharmacokinetics and safety in type 1 diabetes
2012-002071-34Phase 2Completed
- Sponsor
- Dance Pharmaceuticals, Inc.
- Start
- Nov 2012
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2 trial of human insulin in diabetes mellitus type 1 (T1D) (4 arms), sponsored by Dance Pharmaceuticals, Inc. Primary endpoint: AUCINS,0-8h. Started Nov 2012; status: completed.
02
Drugs
human insulin
03
Conditions
diabetes mellitus type 1 (T1D)
Beyond the preview
Go deeper on 2012-002071-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-002071-34.